RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19372549http://www.w3.org/2000/01/rdf-schema#comment"We aimed to gain further understanding of the molecular mechanisms involved in oxaliplatin resistance in colorectal cancer by using a proteomic approach. A 5-fold oxaliplatin-resistant cell line, HTOXAR3, was compared with its parental cell line, HT29, using two-dimensional PAGE. Mass spectrometry, Western blot, and real-time quantitative PCR confirmed the down-regulation of pyruvate kinase M2 (PK-M2) in HTOXAR3 cells. In a panel of eight colorectal cancer cell lines, we found a negative correlation between oxaliplatin resistance and PK-M2 mRNA levels (Spearman r=-0.846, P=0.008). Oxaliplatin exposure in both HT29 and HTOXAR3 led to PK-M2 mRNA up-regulation. PK-M2 mRNA levels were measured by real-time quantitative PCR in 41 tumors treated with oxaliplatin/5-fluorouracil. Tumors with the lowest PK-M2 levels attained the lowest response rates (20% versus 64.5%, P=0.026). High PK-M2 levels were associated with high p53 levels (P=0.032). In conclusion, the data provided clearly link PK-M2 expression and oxaliplatin resistance mechanisms and further implicate PK-M2 as a predictive marker of response in patients with oxaliplatin-treated colorectal cancer."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.org/dc/terms/identifier"doi:10.1158/1535-7163.mct-08-0882"xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Aguilera R."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Abad A."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Neamati N."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Martinez-Cardus A."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Musulen E."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Manzano J.L."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Martinez-Balibrea E."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Gines A."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/author"Plasencia C."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/name"Mol Cancer Ther"xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/pages"771-778"xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/title"A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines."xsd:string
http://purl.uniprot.org/citations/19372549http://purl.uniprot.org/core/volume"8"xsd:string
http://purl.uniprot.org/citations/19372549http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19372549
http://purl.uniprot.org/citations/19372549http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19372549
http://purl.uniprot.org/uniprot/#_A0A4D6DDB2-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549
http://purl.uniprot.org/uniprot/#_A0A4D6DDG8-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549
http://purl.uniprot.org/uniprot/#_A0A4D6DDP3-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549
http://purl.uniprot.org/uniprot/#_A0A977JB91-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549
http://purl.uniprot.org/uniprot/#_B4DPM0-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549
http://purl.uniprot.org/uniprot/#_Q16715-mappedCitation-19372549http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19372549